Menu

WIKIMEDIA, GAGE SKIDMORE

Scott Pruitt Steps Down From EPA

The embattled Environmental Protection Agency Administrator resigns amid persistent questions about his ethics and use of taxpayer dollars.

Jul 5, 2018
Bob Grant

President Donald Trump announced today (July 5) that Scott Pruitt, the former Oklahoma Attorney General he handpicked to lead the Environmental Protection Agency (EPA), has resigned from his post. Making the announcement via Twitter, Trump also indicated that the agency’s Deputy Administrator Andrew Wheeler will assume acting leadership of the EPA starting Monday (July 9).

Pruitt’s resignation comes amid a whirlwind of accusations and investigations into apparent misconduct at the helm of EPA. The ethical red flags raised by Pruitt’s conduct included allegations that he paid a pro-fossil fuel lobbyist a mere $50 per night to rent a Washington, D.C., townhouse, that he sought to use his position to land his wife a “business opportunity” with the chief executive of fast food restaurant Chick-fil-a, and that he enjoyed lavish travel arrangements and treated political appointees to healthy raises, among other activities. Recently, a growing number of conservatives joined the chorus calling for Pruitt to step down.

See “Scott Pruitt's Questionable Practices Exposed

Pruitt was critical of the EPA in his career as Oklahoma Attorney General, suing the agency 13 times to try and stop emissions rules and block regulations that impeded coal-fired power plants and calling for the EPA to be eliminated entirely. In recent weeks, top aides and EPA staffers resigned, as Congress continued to probe Pruitt’s apparent misdealings.

Wheeler, whom Trump appointed as the EPA’s second-in-command, is a former lobbyist that represented America’s largest coal mining company, the erstwhile vice president of the Washington Coal Club, and ex-legislative aide to Senator James Inhofe (R-OK), who is among Congress’s most outspoken climate change deniers. 

See “Pressure Mounts for EPA's Scott Pruitt to Quit

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!